Personalized medicine is a rapidly evolving field. It is about identifying individual’s genomic and clinical information to make the treatment as individualized as the disease. It allows accurate predictions regarding a person's susceptibility to disease, the course of disease, and its response to treatment. With personalized medicine, there will be higher probability of desired outcomes and lower probability of negative side effects due to better-targeted therapies. People will be able to make more informed medical decisions. In addition, people will be able to focus on prevention and early disease intervention, which will reduce healthcare costs. At this workshop, industry leaders and experts will elaborate personalized medicine from diagnostic, therapeutic and legal points of view.

Partner Janet Xiao will present “IP Challenges to Personalized Medicine and Diagnostics.”